Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.463,34
0,19%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Reneo Pharmaceuticals Inc (RPHM) Reneo Pharmaceuticals Inc (RPHM) Notizie

RPHM

Reneo Pharmaceuticals (RPHM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RPHM
DataOraFonteTitoloSimboloCompagnia
13/05/202415:38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202415:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202413:35GlobeNewswire Inc.Reneo Pharmaceuticals and OnKure Announce Proposed MergerNASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202422:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202413:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
28/03/202412:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateNASDAQ:RPHMReneo Pharmaceuticals Inc
25/03/202412:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:RPHMReneo Pharmaceuticals Inc
05/02/202422:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RPHMReneo Pharmaceuticals Inc
14/12/202315:05GlobeNewswire Inc.Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
22/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202323:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202322:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202313:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
02/11/202312:50GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
25/10/202313:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific MeetingsNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202313:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
06/10/202314:30GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro SummitNASDAQ:RPHMReneo Pharmaceuticals Inc
29/08/202323:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
28/08/202323:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
10/08/202313:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
30/06/202314:25GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics ForumNASDAQ:RPHMReneo Pharmaceuticals Inc
26/06/202314:25GlobeNewswire Inc.Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® IndicesNASDAQ:RPHMReneo Pharmaceuticals Inc
24/06/202301:12Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:RPHMReneo Pharmaceuticals Inc
15/06/202318:44GlobeNewswire Inc.Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023NASDAQ:RPHMReneo Pharmaceuticals Inc
14/06/202312:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RPHMReneo Pharmaceuticals Inc
09/06/202300:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RPHMReneo Pharmaceuticals Inc
07/06/202322:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RPHMReneo Pharmaceuticals Inc
05/06/202322:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RPHMReneo Pharmaceuticals Inc
31/05/202316:38GlobeNewswire Inc.Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare ConferenceNASDAQ:RPHMReneo Pharmaceuticals Inc
31/05/202314:00GlobeNewswire Inc.Reneo Pharmaceuticals to Participate at the Jefferies Healthcare ConferenceNASDAQ:RPHMReneo Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RPHM

La tua Cronologia

COIN
DOWSUSD
Shadows Network
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network